Data gathered: November 14
Alternative Data for ATAI Life Sciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 18,000 | Sign up | Sign up | Sign up |
| Employee Rating | 94 | Sign up | Sign up | Sign up |
| Google Trends | 23 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 149,821 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 21 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,643 | Sign up | Sign up | Sign up |
| Twitter Followers | 12,197 | Sign up | Sign up | Sign up |
| Twitter Mentions | 32 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 93 | Sign up | Sign up | Sign up |
| Linkedin Employees | 89 | Sign up | Sign up | Sign up |
About ATAI Life Sciences
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, with offices in New York, San Diego and Berlin.
| Price | $1.28 |
| Target Price | Sign up |
| Volume | 659,070 |
| Market Cap | $245M |
| Year Range | $1.06 - $2.6 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
Warning: ATAI is at high risk of performing badlyOctober 14 - Seeking Alpha |
|
ATAI Life Sciences (ATAI) Shares Surge Amid Positive Analyst RatingsOctober 3 - GuruFocus |
|
Positive Outlook for ATAI Life Sciences Amidst Upcoming Clinical Trials and Strategic CollaborationsAugust 15 - TipRanks |
|
Buy Rating Affirmed for ATAI Life Sciences with Promising Clinical Outlook and Strategic Pipeline ReprioritizationAugust 15 - TipRanks |
|
Strong Buy Rating for ATAI Life Sciences on Promising Clinical Data and Solid FinancialsAugust 13 - TipRanks |
|
 |
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024August 13 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 40,000 | 10M | -10M | -26M | 0 | -0.160 |
| Q2 '24 | 270,000 | 13M | -13M | -57M | -26M | -0.360 |
| Q1 '24 | 0 | 13M | -13M | -27M | -24M | -0.170 |
| Q4 '23 | 18,000 | 20M | -20M | -18M | -33M | -0.120 |
| Q3 '23 | 87,000 | 14M | -14M | 44M | -27M | -0.280 |
Insider Transactions View All
| Brand Florian filed to sell 328,697 shares at $1.9. May 20 '24 |
| Kirpekar Sahil filed to sell 64,199 shares at $1.9. April 4 '24 |
| Rao Srinivas filed to sell 113,360 shares at $1.9. April 4 '24 |
| Johnson Anne Nagengast filed to sell 73,590 shares at $1.9. April 4 '24 |
| Brand Florian filed to buy 130,000 shares at $1.2. November 20 '23 |
Similar companies
Read more about ATAI Life Sciences (ATAI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of ATAI Life Sciences?
The Market Cap of ATAI Life Sciences is $245M.
What is the current stock price of ATAI Life Sciences?
Currently, the price of one share of ATAI Life Sciences stock is $1.28.
How can I analyze the ATAI stock price chart for investment decisions?
The ATAI stock price chart above provides a comprehensive visual representation of ATAI Life Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ATAI Life Sciences shares. Our platform offers an up-to-date ATAI stock price chart, along with technical data analysis and alternative data insights.
Does ATAI offer dividends to its shareholders?
As of our latest update, ATAI Life Sciences (ATAI) does not offer dividends to its shareholders. Investors interested in ATAI Life Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ATAI Life Sciences?
Some of the similar stocks of ATAI Life Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.